A Prospective Trial of Subxiphoid Pericardiotomy in the Diagnosis and Treatment of Large Pericardial Effusion A Follow-Up Report

Trigt, Peter Van; Douglas, James M.; Smith, Paula; Campbell, P.; Wall, Thomas C.; Kenney, Richard T.; O’Connor, Christopher M.; Sheikh, Khalid H.; Corey, G. Ralph

doi:10.1097/00000658-199312000-00012

Cited by 26 publications

(15 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The complication rate was similar to that reported by Geissbuhler et al [12], however, higher than the reported in other series of thoracoscopy and subxiphoid intervention and may possibly reflect differences in the groups studied and the experience of the team with the procedure [13,14]. The intervention was effective in performing the diagnosis and treatment of pericardial effusions, and allows the accomplishment of associated pleural procedures.…”

Section: Discussionsupporting

confidence: 80%

Drenagem pericárdica videotoracoscópica no tratamento dos derrames pericárdicos

Palma¹,

Gaia

Guilhen

et al. 2009

Rev Bras Cir Cardiovasc

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 80%

Drenagem pericárdica videotoracoscópica no tratamento dos derrames pericárdicos

Palma¹,

Gaia

Guilhen

et al. 2009

Rev Bras Cir Cardiovasc

View full text Add to dashboard Cite

show abstract

“…Effusion recurred in 8 patients in 2 mo and in 9 (16%) in the first year. In the subgroup of neoplastic pericardial effusion (n = 13), the mortality was 54% at 2 mo and 92% at 12 mo follow-up [74] . In a report of 67 patients (26 with cancer, 14 with neoplastic pericardial involvement) treated with subxiphoid pericardial drainage, the overall success rate was 82%, but the median survival was 393 d in cancer patients with negative cytology vs 122 d for those with malignant pericardial involvement.…”

Section: Surgical Treatmentmentioning

confidence: 97%

Neoplastic pericardial disease: Old and current strategies for diagnosis and management

Lestuzzi¹

2010

WJC

View full text Add to dashboard Cite

The prevalence of neoplastic pericardial diseases has changed over time and varies according to diagnostic methods. The diagnostic factor is usually the detection of neoplastic cells within the pericardial fluid or in specimens of pericardium, but the diagnosis may be difficult. Accurate sampling and cytopreparatory techniques, together with ancillary studies, including immunohistochemical tests and neoplastic marker dosage, are essential to obtain a reliable diagnosis. The goals of treatment may be simply to relieve symptoms (cardiac tamponade or dyspnea), to prevent recurrent effusion for a long-term symptomatic benefit, or to treat the local neoplastic disease with the aim of prolonging survival. Immediate relief of symptoms may be obtained with percutaneous drainage or with a surgical approach. For long term prevention of recurrences, various approaches have been proposed: extended drainage, pericardial window (surgical or percutaneous balloon pericardiostomy), sclerosing local therapy, local and/or systemic chemotherapy or radiation therapy (RT) (external or with intrapericardial radionuclides). The outcomes of various therapeutic approaches vary for different tumor types. Lymphoma and leukemias can be successfully treated with systemic chemotherapy; for solid tumors, percutaneous drainage and the use of systemic and/or local sclerosing and antineoplastic therapy seems to offer the best chance of success. The use of "pure" sclerosing agents has been replaced by agents with both sclerosing and antineoplastic activity (bleomycin or thiotepa), which seems to be quite effective in breast cancer, at least when associated with systemic chemotherapy. Local chemotherapy with platinum, mitoxantrone and other agents may lead to good local control of the disease, but the addition of systemic chemotherapy is probably relevant in order to prolong survival. The surgical approach (creation of a pericardial window, even with the mini-invasive method of balloon pericardiostomy) and RT may be useful in recurring effusions or in cases that are refractory to other therapeutic approaches.

show abstract

“…368 hastada uyguladıkla-rı subksifoid perikardiyal yaklaşımda nüks oranını işlemden bir ay sonra %10 olarak bildirmiştir [19]. Duke üniversitesinde yapılan prospektif bir çalış- mada değişik nedenlerle subksifoid perikardiyal pencere açılan hastaların %16'sında bir yıl içinde nüks oluştuğu rapor edildi [18]. Bizim çalışmamız-da bu yöntemin nüks oranı üç ay içinde %17,9 bulunmuş ancak gruplar arasında anlamlı bir farklılık saptanmamıştır.…”

Section: Sağkalım Analiziunclassified

The efficacy of VATS, subxiphoid and minithoracotomy pericardial window for surgical management of symptomatic pericardial effusions

Çelık¹,

Aydemir²,

Uncu³

et al. 2014

Diclemedj

View full text Add to dashboard Cite

show abstract

A Prospective Trial of Subxiphoid Pericardiotomy in the Diagnosis and Treatment of Large Pericardial Effusion A Follow-Up Report

Abstract: These data show that the cause of most large pericardial effusions can be determined by a thorough evaluation accompanied by subxiphoid pericardiotomy. In addition, subxiphoid pericardial biopsy and window creation is safe and effective in the treatment of these effusions.

Cited by 26 publications

References 19 publications

Drenagem pericárdica videotoracoscópica no tratamento dos derrames pericárdicos

Drenagem pericárdica videotoracoscópica no tratamento dos derrames pericárdicos

Neoplastic pericardial disease: Old and current strategies for diagnosis and management

The efficacy of VATS, subxiphoid and minithoracotomy pericardial window for surgical management of symptomatic pericardial effusions

Contact Info

Product

Resources

About